Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

 

Cleveland Clinic Rheumatology
Avatar

Preventing Infections in Patients Treated with Biologics

By Cleveland Clinic Rheumatology FEATURING Cassandra Calabrese
By Cleveland Clinic Rheumatology FEATURING Cassandra Calabrese
515 views
January 15, 2019
2 Comments
Login to view comments. Click here to Login
RA
54:18
John Tesser

Beyond TNF Blockade: Breakthroughs in Rheumatoid Arthritis Pathogene…

20:34
Cleveland Clinic Rheumatology

CVD in RA: Need for Management of CVD in RA, CV Risk Calculation &am…

Feat. W. Rigby
29:07
Cleveland Clinic Rheumatology

RA: Use of Imaging to Predict Transition to RA, the Changing Landsca…

Feat. W. Rigby
20:18
Cleveland Clinic Rheumatology

Red Eye in RA: What Is the Differential Diagnosis in General and in …

Feat. J. Rosenbaum
15:06
Cleveland Clinic Rheumatology

Interstitial Lung Disease Update: Should We Treat Asymptomatic ILD? …

Feat. J. Parambil
Cleveland Clinic Rheumatology

Interstitial Lung Disease: What Are the Most Important Advances in C…

Feat. J. Parambil
10:45
Cleveland Clinic Rheumatology

Connective Tissue Disease-Associated Interstitial Lung Disease: Why …

Feat. J. Parambil
07:12
Cleveland Clinic Rheumatology

Tapering vs. Continuing Glucocorticoids in RA: Do Autoantibody Level…

Feat. A. Kavanaugh, J. Cush
05:34
Cleveland Clinic Rheumatology

bDMARDs and nbDMARDs in RA: Is VTE a Clinical Concern in RA?

Feat. A. Kavanaugh, J. Cush
05:59
Cleveland Clinic Rheumatology

Rheumatic Diseases & JAKi Efficacy Results: Is TYK2 Effective in…

Feat. A. Kavanaugh, J. Cush
12:33
Cleveland Clinic Rheumatology

RA & 8 TNFi Biosimilars Efficacy Analysis: Can Multiple bDMARD S…

Feat. A. Kavanaugh, J. Cush
07:54
Cleveland Clinic Rheumatology

bDMARDS in RA: Why Do Patients With Low Levels of 1st TNFi Respond B…

Feat. A. Kavanaugh, J. Cush
08:31
Cleveland Clinic Rheumatology

Refractory Pain in Early RA: What Are the Alternative Treatment Stra…

Feat. A. Kavanaugh, J. Cush
20:57
Cleveland Clinic Rheumatology

IMIDs & Vaccines Update: What Are the Updated Immunization Recom…

Feat. C. Calabrese
05:59
Cleveland Clinic Rheumatology

Rheumatology – Oncology: Cases with the Masters

Feat. L. Calabrese, V. Velcheti
30:39
Cleveland Clinic Rheumatology

T Cell Subsets Overview: Is TH1 Critically Important for Killing Fac…

Feat. J. Looney
24:57
Cleveland Clinic Rheumatology

Links Between Chronic Inflammation and Atherosclerotic Disease and E…

Feat. E. Husni
09:20
Cleveland Clinic Rheumatology

Cardiovascular Risk on RA and PsA Patients: What are the Most Common…

Feat. E. Husni
30:51
Cleveland Clinic Rheumatology

Human Behavior and Immunity – Slowing Aging?

Feat. L. Calabrese
07:40
Cleveland Clinic Rheumatology

Management of Rheumatic irAEs: Is ICI Therapy Safe For Patients With…

Feat. C. Calabrese
22:30
Cleveland Clinic Rheumatology

Immune Related Adverse Events from Cancer Immunotherapy: The Role of…

Feat. C. Calabrese
Cleveland Clinic Rheumatology

Cases with the Masters Discussion: Vasculitis, Co-morbidities, Rheum…

Feat. J. Looney, C. Calabrese
14:45
Cleveland Clinic Rheumatology

Case Review of 40-Year-Old Male HIV-infected Patient With Severe Pol…

Feat. J. Looney, C. Calabrese
41:07
Cleveland Clinic Rheumatology

Cases with the Masters: Clinical Challenges in Rheumatoid Arthritis

Feat. L. Calabrese, E. Keystone, A. Kavanaugh, I. Mcinnes, J. Kay, J. Cush
18:57
Cleveland Clinic Rheumatology

Targeting the IL1 Family in Autoimmune and Autoinflammatory Diseases

Feat. J. Looney
50:27
Cleveland Clinic Rheumatology

Biologics Across Immune-Mediated Inflammatory Diseases from the Rheu…

Feat. A. Kavanaugh, J. Cush
29:26
Cleveland Clinic Rheumatology

Predicting Outcomes in RA - The Role of Biomarkers

Feat. J. Kay
53:53
Cleveland Clinic Rheumatology

Pre-Rheumatoid Arthritis: Can We Define It and Prevent Its Progressi…

Feat. M. Holers
45:10
Cleveland Clinic Rheumatology

Cytokine Profiles in Health and Disease

Feat. I. Mcinnes
37:02
Cleveland Clinic Rheumatology

Increased Inflammation and Disease Activity Among Current Cigarette …

Feat. T. Mikuls
32:24
Cleveland Clinic Rheumatology

IgA Plasmablasts Are Evaluated in Subjects at Risk for Future Rheuma…

Feat. L. Calabrese, M. Holers
32:50
Cleveland Clinic Rheumatology

Advances in Rheumatoid Arthritis

Feat. W. Rigby
16:17
Cleveland Clinic Rheumatology

PPACMAN Update (Rheumatology/Dermatology)

Feat. J. Merola
19:34
Cleveland Clinic Rheumatology

Preventing Infections in Patients Treated with Biologics

Feat. C. Calabrese
23:36
Cleveland Clinic Rheumatology

Revisiting Anti-TNF 20 Years Later

Feat. J. Looney
16:50
Cleveland Clinic Rheumatology

T-Cell and B-Cell (and Other) Targeting in IMIDs

Feat. G. Silverman
17:28
Cleveland Clinic Rheumatology

IL6 Targeting

Feat. L. Calabrese
24:08
Cleveland Clinic Rheumatology

Tailoring Therapy Based on Disease Duration: Is There A Window of Op…

Feat. E. Keystone
26:10
Cleveland Clinic Rheumatology

Predicting the Outcome of Treatment De-Escalation or Discontinuation…

Feat. A. Kavanaugh
30:39
Cleveland Clinic Rheumatology

Herpes Zoster and the Risk of Stroke in Patients with Autoimmune Dis…

Feat. L. Calabrese, C. Calabrese
60:16
Cleveland Clinic Rheumatology

Why Personal Behavior Affects Immune Mediated Inflammatory Diseases

Feat. L. Calabrese
21:51
Cleveland Clinic Rheumatology

Anti-Drug Antibodies, Random Drug Levels with Efficacy in Certolizum…

Feat. L. Calabrese, M. Jani